259 related articles for article (PubMed ID: 10229410)
1. Testing an instrument to screen for fibromyalgia syndrome in general population studies: the London Fibromyalgia Epidemiology Study Screening Questionnaire.
White KP; Harth M; Speechley M; Ostbye T
J Rheumatol; 1999 Apr; 26(4):880-4. PubMed ID: 10229410
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of fibromyalgia: a survey in five European countries.
Branco JC; Bannwarth B; Failde I; Abello Carbonell J; Blotman F; Spaeth M; Saraiva F; Nacci F; Thomas E; Caubère JP; Le Lay K; Taieb C; Matucci-Cerinic M
Semin Arthritis Rheum; 2010 Jun; 39(6):448-53. PubMed ID: 19250656
[TBL] [Abstract][Full Text] [Related]
3. The London Fibromyalgia Epidemiology Study: comparing the demographic and clinical characteristics in 100 random community cases of fibromyalgia versus controls.
White KP; Speechley M; Harth M; Ostbye T
J Rheumatol; 1999 Jul; 26(7):1577-85. PubMed ID: 10405948
[TBL] [Abstract][Full Text] [Related]
4. Sphygmomanometry-evoked allodynia--a simple bedside test indicative of fibromyalgia: a multicenter developmental study.
Vargas A; Vargas A; Hernández-Paz R; Sánchez-Huerta JM; Romero-Ramírez R; Amezcua-Guerra L; Kooh M; Nava A; Pineda C; Rodríguez-Leal G; Martínez-Lavín M
J Clin Rheumatol; 2006 Dec; 12(6):272-4. PubMed ID: 17149055
[TBL] [Abstract][Full Text] [Related]
5. The London Fibromyalgia Epidemiology Study: the prevalence of fibromyalgia syndrome in London, Ontario.
White KP; Speechley M; Harth M; Ostbye T
J Rheumatol; 1999 Jul; 26(7):1570-6. PubMed ID: 10405947
[TBL] [Abstract][Full Text] [Related]
6. A general population study of fibromyalgia tender points in noninstitutionalized adults with chronic widespread pain.
White KP; Harth M; Speechley M; Ostbye T
J Rheumatol; 2000 Nov; 27(11):2677-82. PubMed ID: 11093453
[TBL] [Abstract][Full Text] [Related]
7. Fibromyalgia syndrome in an Amish community: a controlled study to determine disease and symptom prevalence.
White KP; Thompson J
J Rheumatol; 2003 Aug; 30(8):1835-40. PubMed ID: 12913943
[TBL] [Abstract][Full Text] [Related]
8. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with fibromyalgia.
Wolfe F; Michaud K
J Rheumatol; 2004 Apr; 31(4):695-700. PubMed ID: 15088293
[TBL] [Abstract][Full Text] [Related]
9. Quality of life in women with fibromyalgia syndrome: validation of the QIF, the French version of the fibromyalgia impact questionnaire.
Perrot S; Dumont D; Guillemin F; Pouchot J; Coste J;
J Rheumatol; 2003 May; 30(5):1054-9. PubMed ID: 12734906
[TBL] [Abstract][Full Text] [Related]
10. Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis.
Ranzolin A; Brenol JC; Bredemeier M; Guarienti J; Rizzatti M; Feldman D; Xavier RM
Arthritis Rheum; 2009 Jun; 61(6):794-800. PubMed ID: 19479706
[TBL] [Abstract][Full Text] [Related]
11. The London Fibromyalgia Epidemiology Study: direct health care costs of fibromyalgia syndrome in London, Canada.
White KP; Speechley M; Harth M; Ostbye T
J Rheumatol; 1999 Apr; 26(4):885-9. PubMed ID: 10229411
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of fibromyalgia in the Israeli population: a population-based study to estimate the prevalence of fibromyalgia in the Israeli population using the London Fibromyalgia Epidemiology Study Screening Questionnaire (LFESSQ).
Ablin JN; Oren A; Cohen S; Aloush V; Buskila D; Elkayam O; Wollman Y; Berman M
Clin Exp Rheumatol; 2012; 30(6 Suppl 74):39-43. PubMed ID: 23191939
[TBL] [Abstract][Full Text] [Related]
13. Anti-polymer antibodies are correlated with pain and fatigue severity in patients with fibromyalgia syndrome.
Sarzi-Puttini P; Atzeni F; Di Franco M; Lama N; Batticciotto A; Iannuccelli C; Dell'Acqua D; de Portu S; Riccieri V; Carrabba M; Buskila D; Doria A; Valesini G
Autoimmunity; 2008 Feb; 41(1):74-9. PubMed ID: 18176867
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Spanish version of the fibromyalgia rapid screening tool to detect fibromyalgia in primary care health centres.
Casanueva B; Belenguer R; Moreno-Muelas JV; Urtiaga J; Urtiaga B; Hernández JL; Pina T; González-Gay MA
Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S125-8. PubMed ID: 27055283
[TBL] [Abstract][Full Text] [Related]
15. Measuring the epidemiology of distress: the rheumatology distress index.
Wolfe F; Skevington SM
J Rheumatol; 2000 Aug; 27(8):2000-9. PubMed ID: 10955344
[TBL] [Abstract][Full Text] [Related]
16. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms.
Wolfe F; Ross K; Anderson J; Russell IJ
J Rheumatol; 1995 Jan; 22(1):151-6. PubMed ID: 7699662
[TBL] [Abstract][Full Text] [Related]
17. Community screening for rheumatic disorder: cross cultural adaptation and screening characteristics of the COPCORD Core Questionnaire in Brazil, Chile, and Mexico. The PANLAR-COPCORD Working Group. Pan American League of Associations for Rheumatology. Community Oriented Programme for the Control of Rheumatic Disease.
Bennett K; Cardiel MH; Ferraz MB; Riedemann P; Goldsmith CH; Tugwell P
J Rheumatol; 1997 Jan; 24(1):160-8. PubMed ID: 9002028
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of fibromyalgia among textile workers in the city of Denizli in Turkey.
Cobankara V; Unal UO; Kaya A; Bozkurt AI; Ozturk MA
Int J Rheum Dis; 2011 Oct; 14(4):390-4. PubMed ID: 22004238
[TBL] [Abstract][Full Text] [Related]
19. Comparing self-reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario: the London Fibromyalgia Epidemiology Study.
White KP; Speechley M; Harth M; Ostbye T
Arthritis Rheum; 1999 Jan; 42(1):76-83. PubMed ID: 9920017
[TBL] [Abstract][Full Text] [Related]
20. Pain extent and diagnosis: development and validation of the regional pain scale in 12,799 patients with rheumatic disease.
Wolfe F
J Rheumatol; 2003 Feb; 30(2):369-78. PubMed ID: 12563698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
